With more than one million people on treatment in developing countries, we face a growing challenge to keep costs affordable as we reach out to millions more in need.
This agreement will allow the delivery of life-saving medicines to people who desperately need them. It represents a big breakthrough in our efforts to begin treatment programs in places where, until now, there has been virtually no medicine, and therefore no hope.